A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study (opens in new tab)

IntroductionMalnutrition and sarcopenia are prevalent among patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), necessitating simple assessment tools to identify potentially malnourished patients. After describing the nutritional status of those receiving anticancer treatment in Spain, the development of a nutrition screening tool for GEP-NENs was proposed as an exploratory objective of the NUTRIGETNE study.MethodsMalnutrition was defined by Global Leadership Initiative ...